Biotechnology and patent law

Enrico Bonadio

Research output: Contribution to journalArticle

Abstract

This article looks at the impact of biotechnology on traditional patent law. The author argues that biotechnological inventions have unique features, which makes it difficult to use the usual patterns of (legal and factual) interpretation. He stresses that biotech inventions have a sui generis status because (i) biotech products and processes – as opposed to other inventions - relate to living matter and (ii) biotechnology is one of the most R&D-intensive areas. In particular, the author argues that traditional patent rules must be interpreted in a different and more indulgent way when it comes to the patentability of biotech inventions. This entails that the patentability threshold for biotech products and processes is lower than in other fields of technology. It also entails that biotech patents accord to their patentees a wider scope of exclusive rights. However, said lowering and widening have the same purpose, i.e. to give biotech investors and inventors a more favourable legal treatment.
Original languageEnglish
Pages (from-to)1-38
Number of pages38
JournalItalian Intellectual Property
StatePublished - 2009

Fingerprint

invention
biotechnology
patent law
patent
product
process
investor
purpose
technology
area
impact

Cite this

Bonadio, Enrico / Biotechnology and patent law.

In: Italian Intellectual Property, 2009, p. 1-38.

Research output: Contribution to journalArticle

@article{5edfbcd858ab4bb7b8ce3a1c0e4443b9,
title = "Biotechnology and patent law",
abstract = "This article looks at the impact of biotechnology on traditional patent law. The author argues that biotechnological inventions have unique features, which makes it difficult to use the usual patterns of (legal and factual) interpretation. He stresses that biotech inventions have a sui generis status because (i) biotech products and processes – as opposed to other inventions - relate to living matter and (ii) biotechnology is one of the most R&D-intensive areas. In particular, the author argues that traditional patent rules must be interpreted in a different and more indulgent way when it comes to the patentability of biotech inventions. This entails that the patentability threshold for biotech products and processes is lower than in other fields of technology. It also entails that biotech patents accord to their patentees a wider scope of exclusive rights. However, said lowering and widening have the same purpose, i.e. to give biotech investors and inventors a more favourable legal treatment.",
author = "Enrico Bonadio",
year = "2009",
pages = "1--38",
journal = "Italian Intellectual Property",

}

Biotechnology and patent law. / Bonadio, Enrico.

In: Italian Intellectual Property, 2009, p. 1-38.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Biotechnology and patent law

AU - Bonadio,Enrico

PY - 2009

Y1 - 2009

N2 - This article looks at the impact of biotechnology on traditional patent law. The author argues that biotechnological inventions have unique features, which makes it difficult to use the usual patterns of (legal and factual) interpretation. He stresses that biotech inventions have a sui generis status because (i) biotech products and processes – as opposed to other inventions - relate to living matter and (ii) biotechnology is one of the most R&D-intensive areas. In particular, the author argues that traditional patent rules must be interpreted in a different and more indulgent way when it comes to the patentability of biotech inventions. This entails that the patentability threshold for biotech products and processes is lower than in other fields of technology. It also entails that biotech patents accord to their patentees a wider scope of exclusive rights. However, said lowering and widening have the same purpose, i.e. to give biotech investors and inventors a more favourable legal treatment.

AB - This article looks at the impact of biotechnology on traditional patent law. The author argues that biotechnological inventions have unique features, which makes it difficult to use the usual patterns of (legal and factual) interpretation. He stresses that biotech inventions have a sui generis status because (i) biotech products and processes – as opposed to other inventions - relate to living matter and (ii) biotechnology is one of the most R&D-intensive areas. In particular, the author argues that traditional patent rules must be interpreted in a different and more indulgent way when it comes to the patentability of biotech inventions. This entails that the patentability threshold for biotech products and processes is lower than in other fields of technology. It also entails that biotech patents accord to their patentees a wider scope of exclusive rights. However, said lowering and widening have the same purpose, i.e. to give biotech investors and inventors a more favourable legal treatment.

M3 - Article

SP - 1

EP - 38

JO - Italian Intellectual Property

T2 - Italian Intellectual Property

JF - Italian Intellectual Property

ER -